Ibandronate prevents bone loss and reduces vertebral fracture risk in male cardiac transplant patients: a randomized double-blind, placebo-controlled trial. [electronic resource]
Producer: 20090929Description: 1335-44 p. digitalISSN:- 1523-4681
- Acid Phosphatase -- blood
- Adult
- Antacids -- administration & dosage
- Biomarkers -- blood
- Bone Density Conservation Agents -- administration & dosage
- Bone Resorption -- blood
- Calcium Carbonate -- administration & dosage
- Cholecalciferol -- administration & dosage
- Collagen Type I -- blood
- Diphosphonates -- administration & dosage
- Double-Blind Method
- Heart Transplantation
- Humans
- Ibandronic Acid
- Isoenzymes -- blood
- Lumbar Vertebrae -- injuries
- Male
- Middle Aged
- Radiography
- Spinal Fractures -- blood
- Tartrate-Resistant Acid Phosphatase
- Time Factors
- Transplantation, Homologous
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.